COVID-19 inhaler study pulled before it started
NCT ID NCT04356677
First seen Sep 30, 2025 · Last updated May 12, 2026 · Updated 25 times
Summary
This study was designed to see if an inhaled medication called Virazole (ribavirin) could safely help hospitalized adults with severe COVID-19 who had trouble breathing. It was a very early (Phase 1) trial that planned to enroll about 0 participants, but the study was withdrawn before any patients were treated. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.